Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric J Small

Showing results (51-60 of 361) with videos related to

Pageof 37
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancerEric J Small, David F Penson, Oliver Sartor
The Journal of Urology|May 6, 2004
Practice and progress in kidney cancer: methodology for novel drug developmentBrian I Rini, Vivian Weinberg, Eric J Small
Expert Review of Vaccines|October 22, 2015
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future DirectionsXiao X Wei, Lawrence Fong, Eric J Small
Cancer|December 22, 2004
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Eric J Small
Clinical Prostate Cancer|October 4, 2005
Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancerJorge A Garcia, Vivian Weinberg, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancerSusan Halabi, Eric J Small, Nicholas J Vogelzang
Expert Opinion on Biological Therapy|December 25, 2015
Prospects for the use of ipilimumab in treating advanced prostate cancerXiao X Wei, Lawrence Fong, Eric J Small
BJU International|April 29, 2006
Clinical trials in patients with biochemically relapsed prostate cancerAmy M Lin, Brian I Rini, Eric J Small
The New England Journal of Medicine|June 28, 2018
Apalutamide and Metastasis-free Survival in Prostate CancerMatthew R Smith, Margaret K Yu, Eric J Small
Urologic Oncology|May 9, 2006
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationaleCharles J Ryan, Amy M Lin, Eric J Small
Pageof 37

Showing results (51-60 of 361) with videos related to

Sort By:
Pageof 37
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancerEric J Small, David F Penson, Oliver Sartor
The Journal of Urology|May 6, 2004
Practice and progress in kidney cancer: methodology for novel drug developmentBrian I Rini, Vivian Weinberg, Eric J Small
Expert Review of Vaccines|October 22, 2015
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future DirectionsXiao X Wei, Lawrence Fong, Eric J Small
Cancer|December 22, 2004
A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Eric J Small
Clinical Prostate Cancer|October 4, 2005
Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancerJorge A Garcia, Vivian Weinberg, Eric J Small
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancerSusan Halabi, Eric J Small, Nicholas J Vogelzang
Expert Opinion on Biological Therapy|December 25, 2015
Prospects for the use of ipilimumab in treating advanced prostate cancerXiao X Wei, Lawrence Fong, Eric J Small
BJU International|April 29, 2006
Clinical trials in patients with biochemically relapsed prostate cancerAmy M Lin, Brian I Rini, Eric J Small
The New England Journal of Medicine|June 28, 2018
Apalutamide and Metastasis-free Survival in Prostate CancerMatthew R Smith, Margaret K Yu, Eric J Small
Urologic Oncology|May 9, 2006
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationaleCharles J Ryan, Amy M Lin, Eric J Small
Pageof 37